Lacinato Kale (Brassica oleracea var. acephala)

Lacinato kale (Brassica oleracea var. acephala) is a dark leafy green rich in glucosinolates, kaempferol, and lutein that exert anti-inflammatory, neuroprotective, and gut-modulating effects. Its primary bioactive glucosinolates are hydrolyzed into sulforaphane and indole-3-carbinol, which activate Nrf2 antioxidant pathways and modulate NF-κB signaling.

Origin & History

Lacinato kale (Brassica oleracea var. acephala), also known as Tuscan black kale or cavolo nero, is a non-heading variety of kale originating from the Mediterranean region, particularly Italy. It is consumed whole as a fresh or processed food and belongs to the cruciferous vegetable family, rich in glucosinolates, isothiocyanates, and polyphenols.

Historical & Cultural Context

No traditional medicine systems or historical therapeutic use for Lacinato kale were identified in available research. It is noted as a modern functional food with recent research focus rather than having long-standing traditional medicinal applications.

Health Benefits

• Modulates gut microbiota by increasing beneficial Bacteroides bacteria and reducing Firmicutes:Bacteroidetes ratio (mouse study, n=9/group)
• Reduces inflammation markers including TNFα, IL-1β, and MPO activity (rat colitis model, 500 mg/kg dose)
• Provides neuroprotective effects through blood-brain barrier preservation (rat and mouse models)
• Enhances glycan degradation and xenobiotic metabolism pathways (mouse study via PICRUSt2 analysis)
• Contains bioactive glucosinolates that convert to isothiocyanates with anti-inflammatory properties (preclinical evidence)

How It Works

Glucosinolates in lacinato kale are converted by myrosinase into sulforaphane, which activates the Nrf2-Keap1 pathway to upregulate phase II detoxification enzymes including glutathione S-transferase and heme oxygenase-1. Indole-3-carbinol and its metabolite DIM suppress NF-κB signaling, reducing transcription of pro-inflammatory cytokines TNFα and IL-1β, while also inhibiting myeloperoxidase (MPO) activity in intestinal tissue. Kaempferol and lutein cross the blood-brain barrier and scavenge reactive oxygen species, contributing to neuroprotection through mitochondrial membrane stabilization.

Scientific Research

Current evidence for Lacinato kale is limited to preclinical animal models with no human randomized controlled trials identified. Key studies include a 12-week mouse study (PMC7911404) showing gut microbiome modulation, and rat studies demonstrating anti-inflammatory effects in colitis models at 500 mg/kg doses. Bioactivated glucoraphanin from Tuscan black kale showed neuroprotective effects at 10 mg/kg/day in EAE mice models.

Clinical Summary

Preclinical mouse studies (n=9 per group) demonstrate that lacinato kale consumption increases beneficial Bacteroides populations and reduces the Firmicutes:Bacteroidetes ratio, suggesting favorable microbiome modulation. In rat colitis models, oral dosing at 500 mg/kg significantly reduced TNFα, IL-1β, and MPO activity, indicating measurable anti-inflammatory effects in gastrointestinal tissue. Neuroprotective effects have been observed in animal models via blood-brain barrier penetration of lutein and kaempferol, though human clinical trials directly isolating lacinato kale are lacking. Current evidence is promising but largely derived from animal models, and extrapolation to human therapeutic dosing requires further randomized controlled trials.

Nutritional Profile

Per 100g raw lacinato kale: Calories 49 kcal, Protein 4.3g, Carbohydrates 8.8g (Dietary Fiber 3.6g, Sugars 2.3g), Fat 0.9g (including omega-3 ALA ~0.18g). Key vitamins: Vitamin K1 (phylloquinone) ~704µg (587% DV) — bioavailability enhanced by dietary fat co-consumption; Vitamin C ~120mg (133% DV) — partially degraded by heat; Vitamin A (as beta-carotene) ~681µg RAE, with carotenoid bioavailability improved by fat and heat processing; Folate (B9) ~141µg DFE; Vitamin B6 ~0.27mg; Riboflavin (B2) ~0.13mg; Thiamine (B1) ~0.11mg. Key minerals: Calcium ~150mg (though bioavailability reduced ~5% by oxalate content ~17mg/100g); Potassium ~491mg; Magnesium ~47mg; Phosphorus ~92mg; Iron ~1.5mg (non-heme, bioavailability ~5-12%, enhanced by Vitamin C co-consumption); Manganese ~0.66mg; Copper ~0.29mg; Zinc ~0.56mg; Sulfur present via glucosinolates. Bioactive compounds: Glucosinolates (primarily glucoraphanin and sinigrin) ~100-150mg/100g — hydrolyzed by myrosinase enzyme to bioactive isothiocyanates (sulforaphane, allyl isothiocyanate) upon chewing or chopping; Kaempferol ~46.8mg/100g (predominant flavonoid); Quercetin ~22.6mg/100g; Lutein + Zeaxanthin ~39.5mg/100g (bioavailability enhanced ~4-fold by fat); Chlorophyll a and b ~1.5mg/100g combined; Indole-3-carbinol derived from glucobrassicin upon enzymatic hydrolysis. Oxalates ~17mg/100g (relatively low vs. other leafy greens, moderately reducing calcium and iron bioavailability). Cooking note: Boiling reduces glucosinolates by ~30-60% and Vitamin C by ~35-40%, while lightly steaming (~3-4 min) better preserves glucosinolate-myrosinase activity. Bioavailability of fat-soluble nutrients (K1, carotenoids, lutein) significantly increased when consumed with ≥5g dietary fat.

Preparation & Dosage

No clinically studied human dosages have been established for Lacinato kale. Preclinical studies used 500 mg/kg lyophilized kale in rats and 10 mg/kg/day bioactivated glucoraphanin in mice. Kale powder consumption for 8 weeks was noted in general kale studies, but specific standardization details are unavailable. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Probiotics, Turmeric, Omega-3 fatty acids, Vitamin D, Prebiotic fibers

Safety & Interactions

Lacinato kale contains high levels of vitamin K1, which can antagonize warfarin (coumadin) anticoagulation therapy and requires consistent intake monitoring in patients on blood thinners. Its significant oxalate and goitrogen content may pose risks for individuals with kidney stones or hypothyroidism, as raw consumption can inhibit iodine uptake by the thyroid; cooking reduces goitrogenic compounds by approximately 30-40%. High doses may cause gastrointestinal bloating and gas due to fermentable fiber and raffinose content, particularly in individuals with irritable bowel syndrome. Lacinato kale is generally considered safe in food amounts during pregnancy, but concentrated extracts or supplemental doses lack sufficient human safety data for pregnant or lactating women.